Guardian Pharmacy Services (NYSE:GRDN) Stock Price Down 5.9% - Should You Sell?

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) shares traded down 5.9% on Friday . The stock traded as low as $23.64 and last traded at $23.68. 66,701 shares were traded during trading, a decline of 57% from the average session volume of 156,321 shares. The stock had previously closed at $25.17.

Analysts Set New Price Targets

A number of research analysts have issued reports on GRDN shares. Stephens initiated coverage on shares of Guardian Pharmacy Services in a report on Tuesday, October 22nd. They issued an "overweight" rating and a $21.00 target price for the company. Raymond James initiated coverage on Guardian Pharmacy Services in a report on Monday, October 21st. They set an "outperform" rating and a $21.00 price objective for the company. Finally, Truist Financial upped their target price on Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a "buy" rating in a report on Friday, November 15th.

Guardian Pharmacy Services Trading Down 7.6 %

The firm's 50-day moving average is $20.75.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last announced its earnings results on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing analysts' consensus estimates of $0.19 by ($2.19). The business had revenue of $314.39 million during the quarter, compared to analysts' expectations of $303.21 million. Research analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Insider Buying and Selling

In other Guardian Pharmacy Services news, Director Thomas J. Salentine, Jr. bought 35,714 shares of the company's stock in a transaction that occurred on Friday, September 27th. The stock was purchased at an average cost of $14.00 per share, for a total transaction of $499,996.00. Following the completion of the purchase, the director now owns 35,714 shares of the company's stock, valued at $499,996. This trade represents a ∞ increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Steven D. Cosler acquired 7,000 shares of the business's stock in a transaction dated Tuesday, November 19th. The shares were bought at an average price of $21.22 per share, for a total transaction of $148,540.00. Following the completion of the acquisition, the director now owns 17,713 shares in the company, valued at approximately $375,869.86. This trade represents a 65.34 % increase in their ownership of the stock. The disclosure for this purchase can be found here.

Institutional Trading of Guardian Pharmacy Services

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Franklin Resources Inc. acquired a new stake in shares of Guardian Pharmacy Services in the third quarter worth $8,575,000. Virtu Financial LLC acquired a new stake in shares of Guardian Pharmacy Services in the third quarter valued at about $279,000. Barclays PLC purchased a new stake in shares of Guardian Pharmacy Services during the 3rd quarter valued at about $311,000. Wellington Management Group LLP acquired a new position in Guardian Pharmacy Services during the 3rd quarter worth approximately $8,400,000. Finally, Point72 DIFC Ltd purchased a new position in Guardian Pharmacy Services in the 3rd quarter worth approximately $573,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.